Evaluation of metronomic adjuvant chemotherapy

Radiation Therapy

Dr Arun Chandrasekharan‘s article about RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation was published in Oral Oncology Journal.

The article contains the details of a randomized study on metronomic adjuvant therapy in recurrent head and neck cancer who have undergone salvage resection and are ineligible for re-radiation.

Read the full article in the below-attached file or click here to download.

Quick Links

Have a query?

My Picks

Cancer Cells

Can Cancer Cells Be Reversed? Groundbreaking Research Explained

Cancer has always been viewed as a battle—one fought with surgery, chemotherapy, radiation, and advanced immunotherapies. These treatments share a common goal: destroy cancer cells before they destroy the body. But what if, instead of killing cancer cells, we could reprogram them back into healthy, normal cells?

Read More »